Shubin Chen Qitao Yu Wei Jiang Yukun Lu Yun Zhao Huilin Wang
10.3389/fmed.2023.1168220
Front Med (Lausanne)
2023 Jun 29;10:1168220.
egfr exon 19 deletion egfr-tki advanced lung adenocarcinoma immunotherapy rechallenge
CC BY
https://pubmed.ncbi.nlm.nih.gov/37457583/
Case Reports
PMC10339383
37457583
Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report
2023